Clinical Trial Update: Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the optimal duration of antiplatelet therapy after bioresorbable vascular scaffold implantation to reduce late coronary arteria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Seung-Jung Park | Conditions: Percutaneous Transluminal Coronary Angioplasty, Coronary Disease | Phase 4 | Status: COMPLETED